0000905718-21-000828.txt : 20210624 0000905718-21-000828.hdr.sgml : 20210624 20210624174611 ACCESSION NUMBER: 0000905718-21-000828 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210619 FILED AS OF DATE: 20210624 DATE AS OF CHANGE: 20210624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scibetta James S CENTRAL INDEX KEY: 0001383242 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38022 FILM NUMBER: 211043927 MAIL ADDRESS: STREET 1: C/O BIOENVISION, INC. STREET 2: 345 PARK AVENUE, 41ST. FLOOR CITY: NEW YORK STATE: NY ZIP: 10154 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc. CENTRAL INDEX KEY: 0001582554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463011414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 908-484-8805 MAIL ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 matinasbio_fm4jun192021.xml X0306 4 2021-06-19 0 0001582554 Matinas BioPharma Holdings, Inc. MTNB 0001383242 Scibetta James S C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 1 0 0 0 Common Stock, par value $0.0001 per share 2021-06-19 5 J 0 E 4800 0 A 625958 D Common Stock, par value $0.0001 per share 2021-06-19 5 C 0 E 24000 0 A 649958 D Series B Preferred Stock 0.5 2021-06-19 5 C 0 E 12 0 D 2018-06-21 Common Stock 24000 0 D Stock dividend, payable to all holders of record of Series B Preferred Stock of 400 shares of Common Stock for each share of Series B Preferred Stock. On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the "Certificate") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date. /s/ Keith A. Kucinski, attorney-in fact for James S. Scibetta 2021-06-24